Clinical Trials
3 trialsNCT02512926 2025-10-15
POE14-01
Stanford University
Phase 1 Completed
NCT02145403 2022-01-03
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
University of Michigan Rogel Cancer Center
Phase 1/2 Completed
NCT01137747 2016-06-14
AML ALL
Washington University School of Medicine
Phase 1 Completed